Ampio Pharmaceuticals Reaches New 1-Year Low at $4.41 (AMPE)
Ampio Pharmaceuticals (NASDAQ:AMPE)’s share price reached a new 52-week low during trading on Tuesday , StockRatingsNetwork reports. The company traded as low as $4.41 and last traded at $4.50, with a volume of 850,376 shares traded. The stock had previously closed at $4.69.
AMPE has been the subject of a number of recent research reports. Analysts at Jefferies Group downgraded shares of Ampio Pharmaceuticals from a “buy” rating to a “hold” rating in a research note on Friday, August 22nd. They now have a $5.00 price target on the stock, down previously from $14.00. Separately, analysts at Aegis reiterated a “buy” rating on shares of Ampio Pharmaceuticals in a research note on Thursday, August 21st.
The stock has a 50-day moving average of $6.27 and a 200-day moving average of $6.85. The company’s market cap is $233.9 million.
Ampio Pharmaceuticals (NASDAQ:AMPE) last posted its quarterly earnings results on Tuesday, August 12th. The company reported ($0.17) earnings per share for the quarter, beating the analysts’ consensus estimate of ($0.24) by $0.07. On average, analysts predict that Ampio Pharmaceuticals will post $-0.79 earnings per share for the current fiscal year.
Ampio Pharmaceuticals, Inc (NASDAQ:AMPE) is a development-stage biopharmaceutical company focused on the development of therapies to treat prevalent inflammatory conditions for which there are limited treatment options.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.